2023 saw a return to business as usual for the Federal Circuit. Oral arguments are once again in-person and open to the public, and the Court has resumed its former practice of holding occasional sittings outside of...more
This year we are covering three claim construction cases from the Federal Circuit—one coming from the Board and the two from district court. Taken together, the cases are a good reminder of the high burden that a party must...more
1/30/2024
/ Anticipation ,
Appeals ,
Claim Construction ,
Final Written Decisions ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents
Data and Trends: AIA PTAB Appeals to the Federal Circuit (2023 Infographics)...more
Directors Michael Joffre, Ph.D., William H. Milliken, Anna G. Phillips, and Richard A. Crudo will present the webinar "Federal Circuit IP Appeals: Summaries of Key 2023 Decisions" on Tuesday, January 23, 2024, at 1:00 p.m....more
1/19/2024
/ Appellate Courts ,
Claim Construction ,
Continuing Legal Education ,
Design Patent ,
En Banc Review ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
Obviousness ,
Patent Litigation ,
Patent Term Adjustment ,
Patents ,
Trademark Litigation ,
Webinars
Thank you for reading the May 2023 issue of Sterne Kessler's MarkIt to Market® newsletter. This month, we discuss Taco Bell's attempt to cancel two TACO TUESDAY trademark registrations, and a precedential TTAB decision...more
6/1/2023
/ Andy Warhol Foundation for the Visual Arts Inc v Goldsmith ,
Artists ,
Controlled Substances Act ,
Copyright ,
Drug Paraphernalia ,
Functionality ,
Generic Marks ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
Patent Litigation ,
Patents ,
Pharmaceutical Patents ,
SCOTUS ,
The Copyright Act ,
Trademark Registration ,
Trademark Trial and Appeal Board ,
Trademarks ,
Transformative Use ,
USPTO
On May 25, 2023, the US Supreme Court issued its opinion in Dupree v. Younger, which resolved a split among the courts of appeals concerning whether “purely legal” issues raised at the summary-judgment stage must be re-raised...more
It has been nearly thirty years since the US Supreme Court has considered whether a creative work qualifies as a transformative use under the Copyright Act. The last time was in 1994, when the Court in Campbell v. Acuff-Rose...more
5/19/2023
/ Andy Warhol Foundation for the Visual Arts Inc v Goldsmith ,
Artistic Works ,
Artists ,
Copyright ,
Copyright Infringement ,
Copyright Litigation ,
Corporate Counsel ,
Fair Use ,
Intellectual Property Protection ,
SCOTUS ,
The Copyright Act ,
Transformative Use
This morning, the US Supreme Court issued its opinion in Amgen v. Sanofi, a closely watched case concerning patent law’s enablement requirement. Under that requirement, codified at 35 U.S.C. § 112(a), a patent specification...more
5/19/2023
/ Amgen ,
Biotechnology ,
Enablement Inquiries ,
Healthcare ,
Inventions ,
Judicial Proceedings ,
Life Sciences ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Sanofi ,
SCOTUS
On March 27, the U.S. Supreme Court heard oral argument in Amgen v. Sanofi, a closely watched case concerning the appropriate legal standard for patent law's enablement requirement.
That requirement is found in Title 35...more
4/4/2023
/ Amgen ,
Biotechnology ,
Enablement Inquiries ,
Inventions ,
Judicial Proceedings ,
Life Sciences ,
Oral Argument ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Sanofi ,
SCOTUS
On Monday, March 27, 2023, at 10:00 a.m. EDT, the Supreme Court of the United States will hear oral arguments in Amgen Inc. v. Sanofi, No. 21-757. William H. Milliken, a director in Sterne Kessler’s Trial & Appellate Practice...more
3/24/2023
/ Amgen ,
Biotechnology ,
Enablement Inquiries ,
Inventions ,
Judicial Proceedings ,
Life Sciences ,
Online Commentary ,
Oral Argument ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Sanofi ,
SCOTUS
Smith & Nephew petitioned for IPR of Arthrex’s ’907 patent, which claims a surgical device with an “eyelet” through which a suture is threaded. Smith & Nephew argued in relevant part that certain claims were anticipated by a...more
2/15/2023
/ Administrative Patent Judges ,
Anticipation ,
Appointments Clause ,
Arthrex Inc v Smith & Nephew Inc ,
Constitutional Challenges ,
Director of the USPTO ,
Federal Vacancies Reform Act ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Patent Applications ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Separation of Powers ,
Statutory Authority ,
Substantial Evidence ,
USPTO ,
Written Descriptions
Nippon Shinyaku and Sarepta entered into a Mutual Confidentiality Agreement to facilitate discussions about a potential business relationship related to muscular dystrophy therapies. Section 6.1 of the MCA contained a mutual...more
2/15/2023
/ Confidentiality Agreements ,
Covenant Not to Sue ,
Forum Selection ,
Intellectual Property Litigation ,
Inter Partes Review (IPR) Proceeding ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patents ,
Preliminary Injunctions ,
USPTO
As part of the recovery from the global COVID-19 pandemic, the U.S. Court of Appeals for the Federal Circuit took steps to return to normal operations. It began requiring live oral arguments in August 2022 and, by November,...more
As part of the recovery from the global COVID-19 pandemic, the U.S. Court of Appeals for the Federal Circuit took steps to return to normal operations. It began requiring live oral arguments in August 2022 and, by November,...more
2/8/2023
/ § 314(d) ,
§ 315(b) ,
35 U.S.C. §315(e)(1) ,
Abuse of Discretion ,
Administrative Patent Judges ,
Administrative Procedure Act ,
America Invents Act ,
Anticipation ,
Apple ,
Appointments Clause ,
Arbitrary and Capricious ,
Arthrex Inc v Smith & Nephew Inc ,
Article III ,
Artificial Intelligence ,
Broadcom ,
Burden of Persuasion ,
Burden of Production ,
Confidentiality Agreements ,
Consent Order ,
Constitutional Challenges ,
Covenant Not to Sue ,
Director of the USPTO ,
Doctrine of Equivalents ,
Estoppel ,
Evidence ,
Ex Partes Reexamination ,
Expert Testimony ,
Failure To Disclose ,
Federal Vacancies Reform Act ,
Final Written Decisions ,
Forum Selection ,
Google ,
Indefiniteness ,
Intel ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
International Trade Commission (ITC) ,
Inventions ,
Inventors ,
Joint Inventors ,
Jurisdiction ,
Lack of Jurisdiction ,
Likelihood of Confusion ,
Motion to Amend ,
Motion to Terminate ,
Obviousness ,
Obviousness-Type Double Patenting (ODP) ,
Parallel Proceedings ,
Patent Act ,
Patent Applications ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patent Prosecution ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Post-Grant Review ,
Preliminary Injunctions ,
Preponderance of the Evidence ,
Prior Art ,
Qualcomm ,
Real Party in Interest ,
Remand ,
Section 101 ,
Section 112 ,
Separation of Powers ,
Standing ,
Statutory Authority ,
Sua Sponte ,
Substantial Evidence ,
Testimony ,
Time-Barred Claims ,
Trademark Application ,
Trademark Infringement ,
Trademark Litigation ,
Trademark Registration ,
Trademark Trial and Appeal Board ,
Trademarks ,
USPTO ,
Vacated ,
Written Descriptions
In conjunction with the release of the firm's year-in-review report, speakers will offer case summaries and analysis of the significant 2022 appellate rulings discussed in the report. Topics of the featured intellectual...more
1/23/2023
/ Consent Order ,
Continuing Legal Education ,
Estoppel ,
Expert Testimony ,
Final Written Decisions ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
International Trade Commission (ITC) ,
Obviousness ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Prior Art ,
Standing ,
Webinars
Thank you for reading the October 2022 issue of Sterne Kessler's MarkIt to Market® newsletter. This month, we discuss an ongoing trademark suit involving a claim of irreparable harm, share the now open gTLD Sunrise periods,...more
10/28/2022
/ Andy Warhol Foundation for the Visual Arts Inc v Goldsmith ,
Cease and Desist ,
Copyright ,
Copyright Infringement ,
Copyright Litigation ,
Domain Name Registration ,
Domain Names ,
Fair Use ,
False Advertising ,
gTLD ,
ICANN ,
Intellectual Property Protection ,
Irreparable Harm ,
Lanham Act ,
Oral Argument ,
Preliminary Injunctions ,
Sunrise Periods ,
Trademark Litigation ,
Trademark Registration ,
Trademarks ,
Unfair or Deceptive Trade Practices ,
Websites
On Wednesday, October 12, 2022, at 10 a.m. EDT, the Supreme Court of the United States will hear oral arguments in The Andy Warhol Foundation for the Visual Arts, Inc. v. Goldsmith, No. 21-869. William H. Milliken, a director...more
This morning, the Supreme Court denied certiorari in the closely-watched patent eligibility case of American Axle v. Neapco. There were no noted dissents and no statements respecting the denial of certiorari. The denial means...more
Alarm.com filed three petitions for inter partes review (IPR) against Vivint, Inc.’s ’513 patent. The Patent Trial and Appeal Board (Board or PTAB) denied institution of the first two petitions because Alarm.com had failed to...more
2/15/2022
/ Arbitrary and Capricious ,
Denial of Institution ,
Ex Partes Reexamination ,
Inter Partes Review (IPR) Proceeding ,
Lack of Authority ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Remand ,
USPTO ,
Vacated
Kannuu Pty Ltd. and Samsung Elecs. Co. Ltd. entered into a non-disclosure agreement (NDA) as part of business discussions concerning Kannuu’s remote control search-and-navigation technology. The NDA contained a...more
Arthrex appealed a final written decision from an inter partes review (IPR) where the U.S. Patent Trial and Appeal Board (PTAB) found all challenged claims of its patent anticipated. On appeal, Arthrex argued that the...more
2/11/2022
/ Administrative Patent Judges ,
Appointments Clause ,
Constitutional Challenges ,
Director of the USPTO ,
Executive Branch ,
Executive Powers ,
Inferior Officers ,
Inter Partes Review (IPR) Proceeding ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Principle Officers ,
United States v Arthrex Inc
[co-author: Jamie Dohopolski]
Last year, the continued global COVID-19 pandemic forced American courts to largely continue the procedures set in place in 2020. The U.S. Court of Appeals for the Federal Circuit was no...more
2/9/2022
/ § 314(d) ,
35 U.S.C. §315(e)(1) ,
Absolute Intervening Rights Doctrine ,
Abuse of Discretion ,
Administrative Patent Judges ,
Administrative Procedure Act ,
America Invents Act ,
Appeals ,
Appointments Clause ,
Arbitrary and Capricious ,
Article of Manufacture ,
Assignor Estoppel ,
Burden of Proof ,
Claim Construction ,
Collateral Estoppel ,
Commercial Success ,
Confidential Information ,
Constitutional Challenges ,
Demand Letter ,
Denial of Institution ,
Design Patent ,
Director of the USPTO ,
Dismissals ,
Doctrine of Prosecution Disclaimer ,
Due Process ,
Equitable Estoppel ,
Estoppel ,
Evidence ,
Ex Partes Reexamination ,
Executive Branch ,
Executive Powers ,
Federal Rules of Evidence ,
Final Written Decisions ,
Forum Selection ,
FRCP 52(c) ,
GATT ,
Inferior Officers ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
Inter Partes Reexamination ,
Inter Partes Review (IPR) Proceeding ,
International Trade Commission (ITC) ,
Intervening Acts ,
Inventions ,
Issue Preclusion ,
Judicial Review ,
Lack of Authority ,
Lack of Jurisdiction ,
Likelihood of Success ,
Minerva Surgical Inc. v Hologic Inc. ,
Motion for Summary Judgment ,
Motivation to Combine ,
Nexus ,
Non-Disclosure Agreement ,
Nonobvious ,
Obviousness ,
Ornamental Design ,
Parallel Proceedings ,
Patent Applications ,
Patent Filings ,
Patent Infringement ,
Patent Litigation ,
Patent Prosecution ,
Patent Trial and Appeal Board ,
Patent Validity ,
Patents ,
Petition for Writ of Certiorari ,
Pharmaceutical Patents ,
Post-Grant Review ,
Pre-GATT ,
Preliminary Injunctions ,
Principle Officers ,
Printed Publications ,
Prior Art ,
Real Party in Interest ,
Remand ,
Reversal ,
Rule 36 ,
Scope of Review ,
SCOTUS ,
Section 325(d) ,
Sua Sponte ,
Substantial Evidence ,
Totality of Evidence ,
United States v Arthrex Inc ,
USPTO ,
Vacated ,
Writ of Mandamus
Sterne, Kessler, Goldstein & Fox invites you to a webinar, "Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2021 Decisions," on Thursday, February 17, 2022.
In conjunction with the release of the firm's...more
2/9/2022
/ Administrative Patent Judges ,
Assignor Estoppel ,
Collateral Estoppel ,
Continuing Legal Education ,
Design Patent ,
Equitable Estoppel ,
Forum Selection ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
International Trade Commission (ITC) ,
Issue Preclusion ,
Minerva Surgical Inc. v Hologic Inc. ,
Nonobvious ,
Patent Applications ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patent Prosecution ,
Patent Trial and Appeal Board ,
Patents ,
Printed Publications ,
United States v Arthrex Inc ,
Webinars
Following the Supreme Court’s decision in United States v. Arthrex, the Federal Circuit issued requests for briefing regarding the decision’s impact in pending PTAB appeals in which an Appointments Clause challenge had been...more
[co-author: Jay Bober, Summer Associate]
The PTAB Strategies and Insights newsletter provides timely updates and insights into how best to handle proceedings at the USPTO. It is designed to increase return on investment for...more
8/2/2021
/ Administrative Patent Judges ,
Administrative Procedure Act ,
Appointments Clause ,
Burden of Proof ,
Claim Construction ,
Denial of Institution ,
Evidence ,
Executive Branch ,
Executive Powers ,
Intel ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
International Trade Commission (ITC) ,
Oral Hearings ,
Parallel Proceedings ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent Validity ,
Patents ,
Petition For Rehearing ,
Prejudice ,
Prior Art ,
Qualcomm ,
Remand ,
SCOTUS ,
Statutory Deadlines ,
Stipulations ,
Sua Sponte ,
United States v Arthrex Inc ,
USPTO ,
Vacated